

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.28377620 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.25072341 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.25072341 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.25072341 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.25072341 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.25072341 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.25072341 |
| 8 | response to peptidoglycan (GO:0032494) | 5.53205108 |
| 9 | * neutrophil activation involved in immune response (GO:0002283) | 5.50879740 |
| 10 | respiratory burst (GO:0045730) | 5.28126124 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.85172621 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 4.69601221 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.66167322 |
| 14 | negative regulation of cell killing (GO:0031342) | 4.66167322 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.64010061 |
| 16 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.50736238 |
| 17 | regulation of interferon-alpha production (GO:0032647) | 4.47576817 |
| 18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.45022831 |
| 19 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.40550030 |
| 20 | response to host immune response (GO:0052572) | 4.28444938 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.28444938 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.28215916 |
| 23 | reactive oxygen species biosynthetic process (GO:1903409) | 4.19682348 |
| 24 | * granulocyte activation (GO:0036230) | 4.17195400 |
| 25 | superoxide anion generation (GO:0042554) | 4.13907034 |
| 26 | detection of other organism (GO:0098543) | 3.98759878 |
| 27 | microglial cell activation (GO:0001774) | 3.92923037 |
| 28 | * neutrophil activation (GO:0042119) | 3.89651691 |
| 29 | * immunoglobulin mediated immune response (GO:0016064) | 3.87915668 |
| 30 | response to host (GO:0075136) | 3.79108321 |
| 31 | response to host defenses (GO:0052200) | 3.79108321 |
| 32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.79108321 |
| 33 | regulation of mononuclear cell migration (GO:0071675) | 3.78727438 |
| 34 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.77220247 |
| 35 | detection of bacterium (GO:0016045) | 3.77025904 |
| 36 | * myeloid cell activation involved in immune response (GO:0002275) | 3.76770643 |
| 37 | eosinophil chemotaxis (GO:0048245) | 3.75851958 |
| 38 | leukocyte aggregation (GO:0070486) | 3.73580246 |
| 39 | detection of external biotic stimulus (GO:0098581) | 3.71566421 |
| 40 | macrophage activation (GO:0042116) | 3.68713596 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.67108315 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.65409004 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.58526902 |
| 44 | lymphocyte chemotaxis (GO:0048247) | 3.56300960 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.51537587 |
| 46 | defense response to protozoan (GO:0042832) | 3.51159539 |
| 47 | cellular extravasation (GO:0045123) | 3.50701975 |
| 48 | eosinophil migration (GO:0072677) | 3.46604225 |
| 49 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.45696591 |
| 50 | positive regulation of type 2 immune response (GO:0002830) | 3.45463549 |
| 51 | response to muramyl dipeptide (GO:0032495) | 3.43127854 |
| 52 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.43080812 |
| 53 | cellular response to type I interferon (GO:0071357) | 3.39859775 |
| 54 | type I interferon signaling pathway (GO:0060337) | 3.39859775 |
| 55 | natural killer cell mediated immunity (GO:0002228) | 3.39680960 |
| 56 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.39680960 |
| 57 | positive regulation of interferon-beta production (GO:0032728) | 3.38871033 |
| 58 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.38476291 |
| 59 | leukocyte mediated cytotoxicity (GO:0001909) | 3.38473534 |
| 60 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.36826219 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.36614811 |
| 62 | T-helper 1 type immune response (GO:0042088) | 3.36286778 |
| 63 | response to type I interferon (GO:0034340) | 3.34963120 |
| 64 | * B cell mediated immunity (GO:0019724) | 3.34328937 |
| 65 | detection of biotic stimulus (GO:0009595) | 3.33925366 |
| 66 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.33689121 |
| 67 | monocyte chemotaxis (GO:0002548) | 3.33414723 |
| 68 | positive regulation of lymphocyte migration (GO:2000403) | 3.32442345 |
| 69 | * regulation of mast cell activation involved in immune response (GO:0033006) | 3.30567246 |
| 70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.30484830 |
| 71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.30068538 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 3.29304957 |
| 73 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.28816329 |
| 74 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28370822 |
| 75 | myeloid dendritic cell differentiation (GO:0043011) | 3.27141564 |
| 76 | regulation of chemokine biosynthetic process (GO:0045073) | 3.26904002 |
| 77 | regulation of tolerance induction (GO:0002643) | 3.25781615 |
| 78 | neutrophil mediated immunity (GO:0002446) | 3.22233565 |
| 79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.21104148 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 3.20108412 |
| 81 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.20019477 |
| 82 | T cell migration (GO:0072678) | 3.19205342 |
| 83 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18938312 |
| 84 | cellular response to zinc ion (GO:0071294) | 3.17002500 |
| 85 | response to protozoan (GO:0001562) | 3.15971122 |
| 86 | negative regulation of interleukin-17 production (GO:0032700) | 3.15504902 |
| 87 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.15378635 |
| 88 | detection of molecule of bacterial origin (GO:0032490) | 3.13091527 |
| 89 | response to interferon-alpha (GO:0035455) | 3.12118509 |
| 90 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.11945137 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 3.10823294 |
| 92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.10405967 |
| 93 | * myeloid leukocyte activation (GO:0002274) | 3.09396608 |
| 94 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.09328700 |
| 95 | phagosome maturation (GO:0090382) | 3.08550443 |
| 96 | cellular response to interferon-beta (GO:0035458) | 3.08108142 |
| 97 | positive regulation of heat generation (GO:0031652) | 3.07869359 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06461275 |
| 99 | * regulation of leukocyte degranulation (GO:0043300) | 3.05822689 |
| 100 | negative regulation of mast cell activation (GO:0033004) | 3.04928581 |
| 101 | * positive regulation of mast cell degranulation (GO:0043306) | 3.04498554 |
| 102 | * positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.04498554 |
| 103 | * regulation of mast cell activation (GO:0033003) | 3.01399665 |
| 104 | response to interferon-beta (GO:0035456) | 3.00275487 |
| 105 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.99454218 |
| 106 | leukocyte degranulation (GO:0043299) | 2.97907123 |
| 107 | cellular response to interferon-gamma (GO:0071346) | 2.97697855 |
| 108 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.97422813 |
| 109 | * regulation of mast cell degranulation (GO:0043304) | 2.96101143 |
| 110 | negative regulation of interleukin-12 production (GO:0032695) | 2.96043331 |
| 111 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.95643941 |
| 112 | germinal center formation (GO:0002467) | 2.94497525 |
| 113 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92852785 |
| 114 | regulation of fever generation (GO:0031620) | 2.92757763 |
| 115 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92001024 |
| 116 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.91398656 |
| 117 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91071154 |
| 118 | positive regulation of T cell migration (GO:2000406) | 2.90195445 |
| 119 | glycosphingolipid catabolic process (GO:0046479) | 2.90035539 |
| 120 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.89474703 |
| 121 | response to interferon-gamma (GO:0034341) | 2.88959739 |
| 122 | negative regulation of viral genome replication (GO:0045071) | 2.87473627 |
| 123 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.87336826 |
| 124 | pinocytosis (GO:0006907) | 2.87129079 |
| 125 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86007354 |
| 126 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.85499790 |
| 127 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84515231 |
| 128 | regulation of type 2 immune response (GO:0002828) | 2.84230956 |
| 129 | positive regulation of chemokine production (GO:0032722) | 2.83678004 |
| 130 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.83519579 |
| 131 | regulation of lymphocyte migration (GO:2000401) | 2.82883120 |
| 132 | regulation of interleukin-12 production (GO:0032655) | 2.82613533 |
| 133 | regulation of monocyte chemotaxis (GO:0090025) | 2.82465726 |
| 134 | amino sugar catabolic process (GO:0046348) | 2.80856980 |
| 135 | * positive regulation of mast cell activation (GO:0033005) | 2.80566359 |
| 136 | * positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.80059601 |
| 137 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.79730760 |
| 138 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.78004073 |
| 139 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76325703 |
| 140 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.75591849 |
| 141 | regulation of interleukin-17 production (GO:0032660) | 2.74008569 |
| 142 | * positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.73147675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.43218669 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.35455040 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.66703427 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.66196721 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.34751123 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.09856467 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.90624400 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.62926452 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.59091372 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.58387412 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.36922169 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.30673770 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.97330852 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92644581 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82359561 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.78456483 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75894441 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.66761440 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.66306141 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.43654175 |
| 21 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.31118690 |
| 22 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05885370 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.93742099 |
| 24 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83382648 |
| 25 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.83249302 |
| 26 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.82988325 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82034988 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77796993 |
| 29 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.77324274 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.76972983 |
| 31 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74509286 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70493950 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70198481 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68538840 |
| 35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67698260 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64999670 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64968168 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63626684 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62049901 |
| 40 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.54654878 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54296194 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53063892 |
| 43 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.50031817 |
| 44 | * MAF_26560356_Chip-Seq_TH1_Human | 1.49014126 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45262221 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44724053 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.35909749 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35344489 |
| 49 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31930942 |
| 50 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30107504 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30088010 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26540972 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25322050 |
| 54 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23218749 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22078943 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20017081 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19497306 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16981758 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16692822 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14511230 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12571110 |
| 62 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11323382 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08595310 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05525604 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02240760 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01947860 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01692541 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01586653 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99344613 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99056848 |
| 71 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98029797 |
| 72 | MYC_22102868_ChIP-Seq_BL_Human | 0.96858613 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96319048 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96027451 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91651546 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91325215 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91176529 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89232004 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88604101 |
| 80 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83860808 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83615742 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83546484 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82808052 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82470323 |
| 85 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81991112 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79755040 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77014330 |
| 88 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76924941 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 0.76515272 |
| 90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76120803 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74872412 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73404523 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.72429233 |
| 94 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.72274300 |
| 95 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72030635 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.71900871 |
| 97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.71483392 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71360706 |
| 99 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70585856 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70417403 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.70004999 |
| 102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.69147537 |
| 103 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66586122 |
| 104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.65857131 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65683855 |
| 106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65683855 |
| 107 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.65615342 |
| 108 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.62321890 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62127360 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61353684 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59543378 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.59491250 |
| 113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.58724781 |
| 114 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.57197120 |
| 115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.56842305 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55967785 |
| 117 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.55674860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.40375796 |
| 2 | MP0003436_decreased_susceptibility_to | 4.39582018 |
| 3 | MP0009785_altered_susceptibility_to | 3.91288961 |
| 4 | * MP0002148_abnormal_hypersensitivity_rea | 3.84945056 |
| 5 | MP0006082_CNS_inflammation | 3.70009634 |
| 6 | MP0003303_peritoneal_inflammation | 3.51980338 |
| 7 | * MP0002419_abnormal_innate_immunity | 3.48209056 |
| 8 | * MP0005000_abnormal_immune_tolerance | 3.31403179 |
| 9 | MP0005058_abnormal_lysosome_morphology | 3.17622994 |
| 10 | * MP0005025_abnormal_response_to | 3.14681940 |
| 11 | MP0003724_increased_susceptibility_to | 3.09617371 |
| 12 | MP0005671_abnormal_response_to | 2.80442282 |
| 13 | MP0001790_abnormal_immune_system | 2.73748727 |
| 14 | MP0005387_immune_system_phenotype | 2.73748727 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.71005243 |
| 16 | * MP0002723_abnormal_immune_serum | 2.56660280 |
| 17 | MP0000685_abnormal_immune_system | 2.50028949 |
| 18 | * MP0001800_abnormal_humoral_immune | 2.45838097 |
| 19 | * MP0001819_abnormal_immune_cell | 2.33738560 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.33318255 |
| 21 | MP0004510_myositis | 2.33318154 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.30698918 |
| 23 | MP0002405_respiratory_system_inflammati | 2.09701459 |
| 24 | MP0001853_heart_inflammation | 2.08109306 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.05156428 |
| 26 | * MP0005464_abnormal_platelet_physiology | 2.00791654 |
| 27 | * MP0001845_abnormal_inflammatory_respons | 1.94892206 |
| 28 | MP0003448_altered_tumor_morphology | 1.79484559 |
| 29 | MP0003075_altered_response_to | 1.79478416 |
| 30 | MP0008469_abnormal_protein_level | 1.77189098 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.76104624 |
| 32 | MP0004947_skin_inflammation | 1.74504035 |
| 33 | MP0002006_tumorigenesis | 1.70381846 |
| 34 | MP0005310_abnormal_salivary_gland | 1.67936897 |
| 35 | * MP0009764_decreased_sensitivity_to | 1.67734910 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.67403380 |
| 37 | MP0009840_abnormal_foam_cell | 1.67320811 |
| 38 | * MP0000343_altered_response_to | 1.64270193 |
| 39 | * MP0000716_abnormal_immune_system | 1.63177671 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.59849049 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.57928369 |
| 42 | MP0008004_abnormal_stomach_pH | 1.57314384 |
| 43 | MP0000858_altered_metastatic_potential | 1.53710538 |
| 44 | * MP0002398_abnormal_bone_marrow | 1.49344458 |
| 45 | MP0009278_abnormal_bone_marrow | 1.47849907 |
| 46 | * MP0002998_abnormal_bone_remodeling | 1.39971109 |
| 47 | MP0005166_decreased_susceptibility_to | 1.39747475 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.33263535 |
| 49 | MP0003690_abnormal_glial_cell | 1.32361844 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.31204858 |
| 51 | * MP0002429_abnormal_blood_cell | 1.30410546 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.29375861 |
| 53 | MP0000604_amyloidosis | 1.28083304 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.27467223 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.27126222 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.27126222 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.23977434 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.22794640 |
| 59 | MP0002722_abnormal_immune_system | 1.20749504 |
| 60 | MP0004782_abnormal_surfactant_physiolog | 1.20395813 |
| 61 | MP0003186_abnormal_redox_activity | 1.20265925 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.17493191 |
| 63 | MP0005164_abnormal_response_to | 1.16365904 |
| 64 | MP0001851_eye_inflammation | 1.12378690 |
| 65 | MP0003828_pulmonary_edema | 1.11196857 |
| 66 | MP0005390_skeleton_phenotype | 1.10146130 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.07712319 |
| 68 | MP0002933_joint_inflammation | 1.02291884 |
| 69 | MP0009763_increased_sensitivity_to | 1.01069917 |
| 70 | MP0000569_abnormal_digit_pigmentation | 0.98978129 |
| 71 | MP0010307_abnormal_tumor_latency | 0.96545965 |
| 72 | MP0006054_spinal_hemorrhage | 0.96279284 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.90274975 |
| 74 | MP0000249_abnormal_blood_vessel | 0.83900788 |
| 75 | MP0004883_abnormal_blood_vessel | 0.83843312 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.83104648 |
| 77 | MP0000490_abnormal_crypts_of | 0.82615267 |
| 78 | MP0003195_calcinosis | 0.81564102 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.79193937 |
| 80 | MP0003763_abnormal_thymus_physiology | 0.78589991 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.71816894 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.71204339 |
| 83 | MP0008260_abnormal_autophagy | 0.70345740 |
| 84 | MP0000371_diluted_coat_color | 0.70284977 |
| 85 | MP0002132_abnormal_respiratory_system | 0.70118223 |
| 86 | MP0001542_abnormal_bone_strength | 0.69043002 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.68124120 |
| 88 | MP0008874_decreased_physiological_sensi | 0.68009798 |
| 89 | MP0005365_abnormal_bile_salt | 0.67427596 |
| 90 | * MP0003795_abnormal_bone_structure | 0.67315669 |
| 91 | MP0000920_abnormal_myelination | 0.65745189 |
| 92 | MP0001663_abnormal_digestive_system | 0.65359162 |
| 93 | MP0001873_stomach_inflammation | 0.65125375 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.64718013 |
| 95 | MP0003866_abnormal_defecation | 0.62887210 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.62879722 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.61518866 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.60969829 |
| 99 | MP0008873_increased_physiological_sensi | 0.59919475 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.58918950 |
| 101 | MP0005257_abnormal_intraocular_pressure | 0.56562417 |
| 102 | MP0002254_reproductive_system_inflammat | 0.56234600 |
| 103 | MP0000703_abnormal_thymus_morphology | 0.54536027 |
| 104 | MP0005165_increased_susceptibility_to | 0.54348342 |
| 105 | MP0002090_abnormal_vision | 0.52514389 |
| 106 | MP0003329_amyloid_beta_deposits | 0.51990400 |
| 107 | MP0005647_abnormal_sex_gland | 0.51288153 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50372190 |
| 109 | MP0005381_digestive/alimentary_phenotyp | 0.49021512 |
| 110 | MP0002396_abnormal_hematopoietic_system | 0.48824192 |
| 111 | MP0003091_abnormal_cell_migration | 0.48494984 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.47892574 |
| 113 | MP0005451_abnormal_body_composition | 0.47642301 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.45904864 |
| 115 | MP0000609_abnormal_liver_physiology | 0.45768900 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.97157782 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.46820232 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.22185441 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.58978139 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.53074603 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.19862627 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.14232275 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.79324740 |
| 9 | Obstructive lung disease (HP:0006536) | 4.46544659 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.46544659 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 4.46205019 |
| 12 | Gingivitis (HP:0000230) | 4.39172416 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.36477956 |
| 14 | Recurrent skin infections (HP:0001581) | 4.35745012 |
| 15 | Stomatitis (HP:0010280) | 4.34670228 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.29959482 |
| 17 | Myositis (HP:0100614) | 4.23094048 |
| 18 | Disinhibition (HP:0000734) | 4.05087612 |
| 19 | Axonal loss (HP:0003447) | 4.02114337 |
| 20 | Orchitis (HP:0100796) | 3.99391659 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.89274448 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.81390386 |
| 23 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.78963358 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.75663526 |
| 25 | Optic neuritis (HP:0100653) | 3.75663526 |
| 26 | Glomerulonephritis (HP:0000099) | 3.70214768 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.47899027 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.47899027 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.47899027 |
| 30 | Basal ganglia calcification (HP:0002135) | 3.36973720 |
| 31 | Agnosia (HP:0010524) | 3.32520959 |
| 32 | Dysostosis multiplex (HP:0000943) | 3.22716616 |
| 33 | Vasculitis (HP:0002633) | 3.21077764 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.16217233 |
| 35 | Urticaria (HP:0001025) | 3.14638771 |
| 36 | Amyloidosis (HP:0011034) | 3.12034834 |
| 37 | Cellulitis (HP:0100658) | 3.08158750 |
| 38 | Mutism (HP:0002300) | 3.06073707 |
| 39 | Recurrent viral infections (HP:0004429) | 2.99741019 |
| 40 | Periodontitis (HP:0000704) | 2.93392314 |
| 41 | Meningitis (HP:0001287) | 2.91187979 |
| 42 | Pustule (HP:0200039) | 2.86866000 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.86838822 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.83660217 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.83660217 |
| 46 | Prostate neoplasm (HP:0100787) | 2.79234011 |
| 47 | Recurrent pneumonia (HP:0006532) | 2.75039665 |
| 48 | Increased serum ferritin (HP:0003281) | 2.74752212 |
| 49 | Petechiae (HP:0000967) | 2.73315746 |
| 50 | Encephalitis (HP:0002383) | 2.71810135 |
| 51 | Thick nail (HP:0001805) | 2.70821761 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.69800160 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.65627014 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.58817272 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58817272 |
| 56 | Increased IgM level (HP:0003496) | 2.58753674 |
| 57 | T lymphocytopenia (HP:0005403) | 2.54135404 |
| 58 | Hepatosplenomegaly (HP:0001433) | 2.50294277 |
| 59 | Osteomyelitis (HP:0002754) | 2.46730424 |
| 60 | Nephritis (HP:0000123) | 2.45932878 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.41658569 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41441820 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41441820 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41441820 |
| 65 | Chest pain (HP:0100749) | 2.41302400 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.40929281 |
| 67 | Gangrene (HP:0100758) | 2.37726022 |
| 68 | Leukocytosis (HP:0001974) | 2.37006305 |
| 69 | Pulmonary embolism (HP:0002204) | 2.36304631 |
| 70 | Upper motor neuron abnormality (HP:0002127) | 2.34631854 |
| 71 | Recurrent lower respiratory tract infections (HP:0002783) | 2.33337302 |
| 72 | Poor head control (HP:0002421) | 2.29860433 |
| 73 | Hemoptysis (HP:0002105) | 2.28605670 |
| 74 | Polyneuropathy (HP:0001271) | 2.28515296 |
| 75 | Arterial thrombosis (HP:0004420) | 2.24173807 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.24077464 |
| 77 | Abnormality of complement system (HP:0005339) | 2.20530579 |
| 78 | Episodic fever (HP:0001954) | 2.20175942 |
| 79 | Pathologic fracture (HP:0002756) | 2.20047841 |
| 80 | Premature loss of primary teeth (HP:0006323) | 2.17742632 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 2.17499752 |
| 82 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.17086932 |
| 83 | Tetraparesis (HP:0002273) | 2.14975580 |
| 84 | Vertigo (HP:0002321) | 2.12668378 |
| 85 | Gingival bleeding (HP:0000225) | 2.12418010 |
| 86 | Chronic otitis media (HP:0000389) | 2.12299560 |
| 87 | Bone pain (HP:0002653) | 2.11658372 |
| 88 | Increased IgE level (HP:0003212) | 2.10979879 |
| 89 | Myocardial infarction (HP:0001658) | 2.10889798 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 2.10141500 |
| 91 | Joint hemorrhage (HP:0005261) | 2.07364600 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 2.06520194 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06520194 |
| 94 | Neurofibrillary tangles (HP:0002185) | 2.06365628 |
| 95 | Sepsis (HP:0100806) | 2.04683178 |
| 96 | Purpura (HP:0000979) | 2.04556815 |
| 97 | Keratoconjunctivitis (HP:0001096) | 2.03239814 |
| 98 | Abnormality of the prostate (HP:0008775) | 2.03223896 |
| 99 | Inappropriate behavior (HP:0000719) | 2.02972184 |
| 100 | Loss of speech (HP:0002371) | 2.01287890 |
| 101 | Progressive visual loss (HP:0000529) | 1.99675206 |
| 102 | Memory impairment (HP:0002354) | 1.98714897 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.97664978 |
| 104 | Neuronal loss in central nervous system (HP:0002529) | 1.97166892 |
| 105 | Glomerulopathy (HP:0100820) | 1.95952440 |
| 106 | Complement deficiency (HP:0004431) | 1.95677400 |
| 107 | Inflammation of the large intestine (HP:0002037) | 1.93549929 |
| 108 | Anorexia (HP:0002039) | 1.92896036 |
| 109 | Gastrointestinal infarctions (HP:0005244) | 1.92842266 |
| 110 | Abnormality of the pleura (HP:0002103) | 1.90385132 |
| 111 | Joint swelling (HP:0001386) | 1.88799289 |
| 112 | Conjunctival telangiectasia (HP:0000524) | 1.88796231 |
| 113 | Diminished motivation (HP:0000745) | 1.88638901 |
| 114 | Autoimmune hemolytic anemia (HP:0001890) | 1.88207551 |
| 115 | Nausea (HP:0002018) | 1.87203585 |
| 116 | Hematochezia (HP:0002573) | 1.86726916 |
| 117 | Arthralgia (HP:0002829) | 1.86559501 |
| 118 | Abnormality of T cell number (HP:0011839) | 1.84233064 |
| 119 | Eosinophilia (HP:0001880) | 1.84223542 |
| 120 | Abnormality of the pericardium (HP:0001697) | 1.84100995 |
| 121 | Apathy (HP:0000741) | 1.82453503 |
| 122 | Skin ulcer (HP:0200042) | 1.82412337 |
| 123 | Thyroiditis (HP:0100646) | 1.81123874 |
| 124 | Epistaxis (HP:0000421) | 1.80137996 |
| 125 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.78827781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.70233436 |
| 2 | RIPK4 | 4.55797557 |
| 3 | MAP3K14 | 4.04691151 |
| 4 | IRAK4 | 3.68304630 |
| 5 | TBK1 | 3.29908608 |
| 6 | PBK | 3.28892333 |
| 7 | IRAK3 | 2.93526776 |
| 8 | TYK2 | 2.88939322 |
| 9 | MAP4K1 | 2.52266602 |
| 10 | TXK | 2.46136504 |
| 11 | KIT | 2.43725137 |
| 12 | IKBKE | 2.43319839 |
| 13 | IKBKB | 2.26059251 |
| 14 | ERN1 | 2.15622300 |
| 15 | PIM2 | 2.00210156 |
| 16 | JAK3 | 1.94998355 |
| 17 | JAK1 | 1.74902397 |
| 18 | NME2 | 1.74255918 |
| 19 | CSK | 1.67315787 |
| 20 | SYK | 1.60747855 |
| 21 | ZAP70 | 1.59558293 |
| 22 | NEK9 | 1.59255489 |
| 23 | TAOK1 | 1.55403097 |
| 24 | TNK2 | 1.49984461 |
| 25 | BTK | 1.47407240 |
| 26 | TGFBR2 | 1.45678350 |
| 27 | HCK | 1.40878876 |
| 28 | TEC | 1.37557719 |
| 29 | ABL2 | 1.31056053 |
| 30 | PRPF4B | 1.27431725 |
| 31 | CSF1R | 1.27404188 |
| 32 | GRK7 | 1.27257239 |
| 33 | * LYN | 1.26177906 |
| 34 | TAOK3 | 1.24458854 |
| 35 | CHUK | 1.22212423 |
| 36 | PIM1 | 1.21482090 |
| 37 | BMPR2 | 1.20961259 |
| 38 | MAP3K13 | 1.20228633 |
| 39 | FES | 1.14324253 |
| 40 | FGR | 1.13244679 |
| 41 | MATK | 1.13070491 |
| 42 | LCK | 1.12925749 |
| 43 | CLK1 | 1.11903897 |
| 44 | BMX | 1.09355846 |
| 45 | TESK2 | 1.07104480 |
| 46 | JAK2 | 1.03770146 |
| 47 | RPS6KA4 | 1.02982082 |
| 48 | ACVR1B | 1.01525014 |
| 49 | STK10 | 0.95429586 |
| 50 | DDR2 | 0.95025849 |
| 51 | EIF2AK2 | 0.93411468 |
| 52 | MST4 | 0.91143814 |
| 53 | CDC42BPA | 0.90877173 |
| 54 | YES1 | 0.89715524 |
| 55 | STK4 | 0.89111577 |
| 56 | TRPM7 | 0.86896838 |
| 57 | EPHB1 | 0.85493725 |
| 58 | MAP2K3 | 0.85264537 |
| 59 | PRKCD | 0.81575324 |
| 60 | MARK3 | 0.75613724 |
| 61 | RIPK1 | 0.73383032 |
| 62 | MST1R | 0.71531239 |
| 63 | MAP3K12 | 0.71452049 |
| 64 | CDK19 | 0.71395538 |
| 65 | ABL1 | 0.68905783 |
| 66 | ERBB3 | 0.67714885 |
| 67 | ARAF | 0.67091279 |
| 68 | ITK | 0.66714508 |
| 69 | ADRBK2 | 0.62691574 |
| 70 | KDR | 0.61549264 |
| 71 | EGFR | 0.60928257 |
| 72 | MAP3K5 | 0.60163255 |
| 73 | MAP3K11 | 0.58921247 |
| 74 | DAPK2 | 0.56456838 |
| 75 | IRAK2 | 0.54778576 |
| 76 | MAPK7 | 0.49693388 |
| 77 | MAPK12 | 0.49489532 |
| 78 | FGFR3 | 0.49380401 |
| 79 | MOS | 0.48671439 |
| 80 | EIF2AK3 | 0.46957518 |
| 81 | MAP2K6 | 0.46286687 |
| 82 | LRRK2 | 0.45195632 |
| 83 | TESK1 | 0.44993419 |
| 84 | KSR2 | 0.43693319 |
| 85 | RPS6KA6 | 0.42411250 |
| 86 | IRAK1 | 0.41873571 |
| 87 | MARK2 | 0.41408511 |
| 88 | MAPKAPK2 | 0.40573992 |
| 89 | CDK6 | 0.39827685 |
| 90 | SIK3 | 0.39596069 |
| 91 | PRKCQ | 0.39107055 |
| 92 | FYN | 0.38775478 |
| 93 | GRK6 | 0.38577109 |
| 94 | CAMKK2 | 0.38545863 |
| 95 | SCYL2 | 0.37390815 |
| 96 | MAP3K3 | 0.33347704 |
| 97 | PAK4 | 0.32047485 |
| 98 | CAMK1D | 0.32046620 |
| 99 | PIK3CG | 0.31377818 |
| 100 | MAP3K1 | 0.31075741 |
| 101 | PTK2B | 0.30115619 |
| 102 | STK24 | 0.29810675 |
| 103 | RPS6KL1 | 0.29232192 |
| 104 | RPS6KC1 | 0.29232192 |
| 105 | SIK2 | 0.28828451 |
| 106 | IGF1R | 0.28349290 |
| 107 | MAP3K6 | 0.27987659 |
| 108 | EPHA3 | 0.26466266 |
| 109 | STK3 | 0.26447786 |
| 110 | BMPR1B | 0.25591813 |
| 111 | TAOK2 | 0.25508771 |
| 112 | MAP3K10 | 0.25439935 |
| 113 | DAPK3 | 0.23724189 |
| 114 | INSR | 0.22882770 |
| 115 | PDK1 | 0.22843086 |
| 116 | PRKD2 | 0.22246239 |
| 117 | RPS6KA2 | 0.21817365 |
| 118 | MAPK4 | 0.21798740 |
| 119 | CDK4 | 0.21730991 |
| 120 | HIPK2 | 0.21507989 |
| 121 | PDPK1 | 0.20488198 |
| 122 | PRKG2 | 0.20378030 |
| 123 | TLK1 | 0.19980143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.68333305 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.53532342 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.39411127 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.83466952 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.61237901 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53493641 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.50579490 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.47304606 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.46102989 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.43060013 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.36931208 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.36103598 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.28572067 |
| 14 | * Tuberculosis_Homo sapiens_hsa05152 | 2.24858615 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19873262 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11330491 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05678774 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.99031700 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98835283 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.98240538 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.95450878 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.93718593 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78945429 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73887195 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.65958700 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65667769 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.63555789 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61694347 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60358439 |
| 30 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55435518 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50605283 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46883584 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.44313097 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44263874 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41790723 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39994293 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.35000272 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.33574502 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30189033 |
| 40 | * Asthma_Homo sapiens_hsa05310 | 1.24054760 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14843526 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05250585 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.02755848 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02356253 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01583031 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99677350 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.99398403 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98915648 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93462910 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90367937 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88696005 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88537696 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86029379 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.84962592 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.84632251 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83581103 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.80813798 |
| 58 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75707056 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75633307 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66610133 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66028316 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64767371 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62434284 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55727567 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52232182 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52231083 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48757514 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48569111 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48462511 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47909536 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.47788895 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47583401 |
| 73 | * Platelet activation_Homo sapiens_hsa04611 | 0.45931372 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45291517 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.45216245 |
| 76 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43989119 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39785416 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38873182 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38211650 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33730681 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32984439 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.32744981 |
| 83 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31142564 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29264939 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28997162 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28547224 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26310675 |
| 88 | Proteasome_Homo sapiens_hsa03050 | 0.25747987 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24296519 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20748178 |
| 91 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19962558 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19458145 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18952614 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18813556 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18419381 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.18281009 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17465898 |
| 98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16644252 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16015242 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15370072 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.14342218 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14287662 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14017515 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14002156 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13159500 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.12945825 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.11403075 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10870968 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09604450 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08733023 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08474594 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07123863 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06305779 |

